Emanuela Marchesi
Emanuela Marchesi
Verified email at ior.it
TitleCited byYear
Photoreduction of the fluorescent dye 2′-7′-dichlorofluorescein: a spin trapping and direct electron spin resonance study with implications for oxidative stress measurements
E Marchesi, C Rota, YC Fann, CF Chignell, RP Mason
Free Radical Biology and Medicine 26 (1-2), 148-161, 1999
1551999
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label …
A Gronchi, S Ferrari, V Quagliuolo, JM Broto, AL Pousa, G Grignani, ...
The Lancet Oncology 18 (6), 812-822, 2017
1392017
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
G Grignani, E Palmerini, V Ferraresi, L D'Ambrosio, R Bertulli, SD Asaftei, ...
The lancet oncology 16 (1), 98-107, 2015
1292015
The nature of prooxidant activity of vitamin C
M Paolini, L Pozzetti, GF Pedulli, E Marchesi, G Cantelli-Forti
Life sciences 64 (23), PL273-PL278, 1999
1181999
Homolytic reactivity of group 14 organometallic hydrides toward nitroxides
M Lucarini, E Marchesi, GF Pedulli, C Chatgilialoglu
The Journal of Organic Chemistry 63 (5), 1687-1693, 1998
761998
Medium effects on the antioxidant activity of dipyridamole
GF Pedulli, M Lucarini, E Marchesi, F Paolucci, S Roffia, D Fiorentini, ...
Free Radical Biology and Medicine 26 (3-4), 295-302, 1999
351999
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): for how long?
E Palmerini, NS Chawla, S Ferrari, M Sudan, P Picci, E Marchesi, ...
European Journal of Cancer 76, 118-124, 2017
332017
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
E Palmerini, M Colangeli, C Nanni, S Fanti, E Marchesi, A Paioli, P Picci, ...
European journal of nuclear medicine and molecular imaging 44 (2), 215-223, 2017
282017
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
E Palmerini, RL Jones, E Marchesi, A Paioli, M Cesari, A Longhi, ...
BMC cancer 16 (1), 280, 2016
252016
sarcoma Full-dose neoadjuvant anthracycline+ ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk …
A Gronchi, S Ferrari, V Quagliuolo, JM Broto, A Lopez-Pousa, G Grignani, ...
Annals of Oncology 27 (suppl_6), LBA6_PR, 2016
212016
Taking EPR" snapshots" of the oxidative stress status in human blood
M Paolini, L Valgimigli, E Marchesi, S Trespidi, GF Pedulli
Free radical research 37 (5), 503-508, 2003
212003
Primary angiosarcoma of bone: A retrospective analysis of 60 patients from two institutions
E Palmerini, RG Maki, EL Staals, M Alberghini, CR Antonescu, C Ferrari, ...
American journal of clinical oncology 37 (6), 528, 2014
202014
Primary angiosarcoma of bone: A retrospective analysis of 60 patients from two institutions
E Palmerini, RG Maki, EL Staals, M Alberghini, CR Antonescu, C Ferrari, ...
American journal of clinical oncology 37 (6), 528, 2014
202014
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
E Palmerini, RL Jones, E Setola, P Picci, E Marchesi, R Luksch, ...
Acta Oncologica 57 (7), 958-964, 2018
132018
High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma?
A Righi, A Paioli, AP Dei Tos, M Gambarotti, E Palmerini, M Cesari, ...
Clinical sarcoma research 5 (1), 23, 2015
92015
Osteosarcoma follow-up: chest X-ray or computed tomography?
A Paioli, M Rocca, L Cevolani, E Rimondi, D Vanel, E Palmerini, M Cesari, ...
Clinical sarcoma research 7 (1), 3, 2017
72017
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age
A Paioli, R Luksch, F Fagioli, A Tamburini, M Cesari, E Palmerini, ...
Journal of chemotherapy 26 (1), 49-56, 2014
72014
IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) Sarcoma Groups phase I/II trial of sunitinib plus nivolumab in selected bone and soft tissue sarcoma subtypes …
J Martin Broto, N Hindi, A Redondo, J Martinez-Trufero, S Stacchiotti, ...
Journal of Clinical Oncology 36 (15_suppl), 11515-11515, 2018
52018
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma
C Peraldo-Neia, P Ostano, G Cavalloni, Y Pignochino, D Sangiolo, ...
BMC genomics 19 (1), 440, 2018
42018
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group
G Grignani, L D'Ambrosio, Y Pignochino, E Palmerini, M Zucchetti, ...
The Lancet Oncology 19 (10), 1360-1371, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20